Lipid metabolizing enzyme ACSM2B is a potential negative regulator of liver cancer progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lipid metabolizing enzyme ACSM2B is a potential negative regulator of liver cancer progression

Published:2024-05 Issue:5 Volume:47 Page:2517-2519
ISSN:1015-9584
Container-title:Asian Journal of Surgery
language:en
Short-container-title:Asian Journal of Surgery

Author:

Xu Zhengfeng^ORCID,Yu Hongwei,Meng Xingchu,Yu Ze^ORCID

Publisher

Elsevier BV

Reference4 articles.

1. Reprogramming of fatty acid metabolism in cancer;Koundouros;Br J Cancer,2020

2. Lipid metabolism reprogramming and its potential targets in cancer;Cheng;Cancer Commun,2018

3. Comparative analyses of disease risk genes belonging to the acyl-CoA synthetase medium-chain (ACSM) family in human liver and cell lines;Boomgaarden;Biochem Genet,2009

4. Analyses of the genetic diversity and protein expression variation of the acyl: CoA medium-chain ligases, ACSM2A and ACSM2B;Van der Sluis;Mol Genet Genom,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP